| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.
|
Nat Genet
|
2010
|
9.90
|
|
2
|
Common variants at CD40 and other loci confer risk of rheumatoid arthritis.
|
Nat Genet
|
2008
|
7.07
|
|
3
|
Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
|
Arthritis Rheum
|
2005
|
5.18
|
|
4
|
High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.
|
Nat Genet
|
2012
|
4.46
|
|
5
|
Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis.
|
Am J Hum Genet
|
2007
|
3.62
|
|
6
|
Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk.
|
Nat Genet
|
2009
|
3.52
|
|
7
|
A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.
|
PLoS Med
|
2007
|
3.41
|
|
8
|
Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.
|
Arthritis Rheum
|
2010
|
2.08
|
|
9
|
Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.
|
Proc Natl Acad Sci U S A
|
2011
|
2.07
|
|
10
|
Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis.
|
Ann Rheum Dis
|
2010
|
1.59
|
|
11
|
Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.
|
Arthritis Rheum
|
2005
|
1.55
|
|
12
|
Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis.
|
PLoS Genet
|
2013
|
1.54
|
|
13
|
A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2.
|
PLoS Genet
|
2008
|
1.53
|
|
14
|
CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity.
|
Proc Natl Acad Sci U S A
|
2002
|
1.34
|
|
15
|
De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid.
|
J Immunol
|
2009
|
1.26
|
|
16
|
Genetics of rheumatoid arthritis: what have we learned?
|
Immunogenetics
|
2011
|
1.21
|
|
17
|
The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases.
|
Ann Rheum Dis
|
2009
|
1.17
|
|
18
|
Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes.
|
Immunol Rev
|
2002
|
1.16
|
|
19
|
Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.
|
Cardiovasc Res
|
2009
|
1.16
|
|
20
|
Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities.
|
Ann Rheum Dis
|
2010
|
1.15
|
|
21
|
Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy.
|
J Virol
|
2003
|
1.11
|
|
22
|
Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion.
|
Crit Rev Oncol Hematol
|
2004
|
1.09
|
|
23
|
Rheumatoid arthritis: Are ACPA-positive and ACPA-negative RA the same disease?
|
Nat Rev Rheumatol
|
2011
|
1.03
|
|
24
|
Transcription of the IL10 gene reveals allele-specific regulation at the mRNA level.
|
Hum Mol Genet
|
2004
|
1.00
|
|
25
|
Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis.
|
Arthritis Rheum
|
2004
|
0.99
|
|
26
|
Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation.
|
Ann Rheum Dis
|
2008
|
0.99
|
|
27
|
Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye.
|
J Immunol
|
2003
|
0.96
|
|
28
|
The inflammatory disease-associated variants in IL12B and IL23R are not associated with rheumatoid arthritis.
|
Arthritis Rheum
|
2008
|
0.90
|
|
29
|
Suppressor activity among CD4+,CD25++ T cells is discriminated by membrane-bound tumor necrosis factor alpha.
|
Arthritis Rheum
|
2008
|
0.88
|
|
30
|
Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis.
|
J Rheumatol
|
2004
|
0.87
|
|
31
|
In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway.
|
J Immunol
|
2002
|
0.87
|
|
32
|
Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case study.
|
Arthritis Res Ther
|
2007
|
0.86
|
|
33
|
Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity.
|
Arthritis Res Ther
|
2012
|
0.86
|
|
34
|
A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis.
|
Arthritis Res Ther
|
2014
|
0.85
|
|
35
|
TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells.
|
Eur J Immunol
|
2014
|
0.85
|
|
36
|
Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis.
|
PLoS One
|
2012
|
0.84
|
|
37
|
Genetics of ACPA-positive rheumatoid arthritis: the beginning of the end?
|
Ann Rheum Dis
|
2011
|
0.84
|
|
38
|
Mechanisms of oral tolerance revisited.
|
Arthritis Res Ther
|
2008
|
0.82
|
|
39
|
Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis.
|
Mod Rheumatol
|
2011
|
0.82
|
|
40
|
ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression.
|
Arthritis Res Ther
|
2013
|
0.82
|
|
41
|
The concentration of anticitrullinated protein antibodies in serum and synovial fluid in relation to total immunoglobulin concentrations.
|
Ann Rheum Dis
|
2013
|
0.81
|
|
42
|
Neutralization of IL-4 reverses the nonresponsiveness of CD4+ T cells to regulatory T-cell induction in non-responder mouse strains.
|
Mol Immunol
|
2010
|
0.81
|
|
43
|
IL-21 enhances the activity of the TLR-MyD88-STAT3 pathway but not the classical TLR-MyD88-NF-κB pathway in human B cells to boost antibody production.
|
J Immunol
|
2013
|
0.81
|
|
44
|
The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA.
|
Arthritis Res Ther
|
2011
|
0.81
|
|
45
|
Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis.
|
Eur J Hum Genet
|
2010
|
0.80
|
|
46
|
TRAF1/C5 polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies.
|
Arthritis Res Ther
|
2010
|
0.80
|
|
47
|
Variants of gene for microsomal prostaglandin E2 synthase show association with disease and severe inflammation in rheumatoid arthritis.
|
Eur J Hum Genet
|
2011
|
0.77
|
|
48
|
The window of opportunity in ACPA-positive rheumatoid arthritis is not explained by ACPA characteristics.
|
Ann Rheum Dis
|
2011
|
0.76
|
|
49
|
Sensing and signaling by the immune system NVVI-Dutch Society for immunology course, Lunteren, April 2-3, 2009.
|
Immunol Lett
|
2009
|
0.75
|
|
50
|
Guiding the action of the immune system: Interactions between the immune system and non-immune tissues: NVVI-Dutch society for Immunology Course, Lunteren, March 31st-April 1st, 2010.
|
Immunol Lett
|
2011
|
0.75
|